These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16934049)

  • 1. Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters.
    Vormfelde SV; Schirmer M; Hagos Y; Toliat MR; Engelhardt S; Meineke I; Burckhardt G; Nürnberg P; Brockmöller J
    Br J Clin Pharmacol; 2006 Sep; 62(3):323-35. PubMed ID: 16934049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].
    Xu G; Bhatnagar V; Wen G; Hamilton BA; Eraly SA; Nigam SK
    Kidney Int; 2005 Oct; 68(4):1491-9. PubMed ID: 16164626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2C9 polymorphisms and the interindividual variability in pharmacokinetics and pharmacodynamics of the loop diuretic drug torsemide.
    Vormfelde SV; Engelhardt S; Zirk A; Meineke I; Tuchen F; Kirchheiner J; Brockmöller J
    Clin Pharmacol Ther; 2004 Dec; 76(6):557-66. PubMed ID: 15592327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation at the CYP2C locus and its association with torsemide biotransformation.
    Vormfelde SV; Schirmer M; Toliat MR; Meineke I; Kirchheiner J; Nürnberg P; Brockmöller J
    Pharmacogenomics J; 2007 Jun; 7(3):200-11. PubMed ID: 16969365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insights into the structure-function relationship of organic anion transporters OATs.
    Zhou F; You G
    Pharm Res; 2007 Jan; 24(1):28-36. PubMed ID: 17103332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of Mardin-Darby canine kidney cells stably expressing human organic anion transporters.
    Shin HJ; Lee CH; Park SJ; Shin JG; Song IS
    Arch Pharm Res; 2010 May; 33(5):709-16. PubMed ID: 20512469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug transport by Organic Anion Transporters (OATs).
    Burckhardt G
    Pharmacol Ther; 2012 Oct; 136(1):106-30. PubMed ID: 22841915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels.
    Buist SC; Klaassen CD
    Drug Metab Dispos; 2004 Jun; 32(6):620-5. PubMed ID: 15155553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency.
    Gehr TW; Rudy DW; Matzke GR; Kramer WG; Sica DA; Brater DC
    Clin Pharmacol Ther; 1994 Jul; 56(1):31-8. PubMed ID: 8033492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heritability of metoprolol and torsemide pharmacokinetics.
    Matthaei J; Brockmöller J; Tzvetkov MV; Sehrt D; Sachse-Seeboth C; Hjelmborg JB; Möller S; Halekoh U; Hofmann U; Schwab M; Kerb R
    Clin Pharmacol Ther; 2015 Dec; 98(6):611-21. PubMed ID: 26344676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamics.
    Vormfelde SV; Toliat MR; Schirmer M; Meineke I; Nürnberg P; Brockmöller J
    Clin Pharmacol Ther; 2008 Jun; 83(6):815-7. PubMed ID: 18043684
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
    Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
    J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of 5' regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3).
    Bhatnagar V; Xu G; Hamilton BA; Truong DM; Eraly SA; Wu W; Nigam SK
    J Hum Genet; 2006; 51(6):575-580. PubMed ID: 16648942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of tissue-specific expression of renal organic anion transporters by hepatocyte nuclear factor 1 α/β and DNA methylation.
    Jin L; Kikuchi R; Saji T; Kusuhara H; Sugiyama Y
    J Pharmacol Exp Ther; 2012 Mar; 340(3):648-55. PubMed ID: 22160269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
    Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
    Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues.
    Nigam SK; Bush KT; Bhatnagar V
    Nat Clin Pract Nephrol; 2007 Aug; 3(8):443-8. PubMed ID: 17653123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1).
    Fujita T; Brown C; Carlson EJ; Taylor T; de la Cruz M; Johns SJ; Stryke D; Kawamoto M; Fujita K; Castro R; Chen CW; Lin ET; Brett CM; Burchard EG; Ferrin TE; Huang CC; Leabman MK; Giacomini KM
    Pharmacogenet Genomics; 2005 Apr; 15(4):201-9. PubMed ID: 15864112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6).
    Wong CC; Botting NP; Orfila C; Al-Maharik N; Williamson G
    Biochem Pharmacol; 2011 Apr; 81(7):942-9. PubMed ID: 21244849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugs.
    Vormfelde SV; Sehrt D; Toliat MR; Schirmer M; Meineke I; Tzvetkov M; Nürnberg P; Brockmöller J
    Clin Pharmacol Ther; 2007 Sep; 82(3):300-9. PubMed ID: 17460608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy.
    Burckhardt G; Burckhardt BC
    Handb Exp Pharmacol; 2011; (201):29-104. PubMed ID: 21103968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.